Inventors:
Michael T. Kelly - Blaine WA, US
Assignee:
Seatek Marine Biotechnology, Inc. - Vancouver
International Classification:
A61K 31/45, A61K 38/08, A61K 45/06, A61P 17/00, A61P 17/10, A61P 31/00
US Classification:
514 11, 514 9, 514 24, 514398
Abstract:
Cyclic peptide antibiotics including the loloatins are effective in the treatment of rosacea, particularly when administered in conjunction with an antibiotic such as metronidazole that is effective against anaerobic bacteria.